Quelofy Technologies Private Limited
Innovating Intelligent Solutions for Pressure Ulcer Prevention
About
Quelofy Technologies Private Limited is a medtech startup focused on improving patient safety and care quality through advanced pressure ulcer prevention technologies.
The company’s flagship solution, Preventix, is an intelligent monitoring and prevention platform designed to address pressure ulcers (bed sores) across acute care hospitals, rehabilitation centers, elderly care facilities, and long-term care environments. Preventix enables continuous assessment of pressure-related risks, supporting early intervention and consistent preventive care.
Founded by Manoj and Keerthana, Quelofy is driven by a mission to deliver clinically meaningful, affordable, and scalable medical technologies. By providing real-time insights and actionable alerts, Quelofy empowers healthcare professionals to reduce preventable complications such as tissue damage, infection, extended hospital stays, and sepsis.
Preventix is designed to:
-
Continuously monitor pressure exposure and patient risk factors
-
Detect early indicators of skin stress before ulcer formation
-
Alert caregivers and clinicians to enable timely preventive action
-
Provide data-informed guidance for patient repositioning
-
Reduce reliance on rigid manual turning protocols
-
Improve patient comfort, safety, and measurable clinical outcomes
-
Expand access to advanced pressure ulcer prevention solutions across India
Company Details
Founders: Manoj and Keerthana
Date of Incorporation: October 15, 2025
Registered Office: No. 171, OM Sai Nagar, Kalluballu, Jigani, Bangalore, Karnataka – 560105
Website: www.quelofy.com
Whether partnering with hospitals aiming to reduce hospital-acquired pressure injuries, long-term care providers focused on standardized prevention, rehabilitation centers managing complex patient mobility, or clinicians seeking next-generation prevention tools, Quelofy Technologies delivers solutions aligned with modern clinical needs.
Quelofy is not simply developing medical technology—it is advancing a proactive, data-driven standard of care for pressure ulcer prevention.
The future of prevention is intelligent. The future is Preventix.